Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03374631 · ClinicalTrials.gov registry record · NA

Stimulating the Social Brain

A NA study of Healthy Adults, sponsored by The University of Texas at Dallas.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03374631 is a NA study of Healthy Adults that has completed, run by The University of Texas at Dallas. The registered enrollment target is 40 participants, below the 85-participant average among 33 other Healthy Adults trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03374631, a NA study of Healthy Adults, has completed, sponsored by The University of Texas at Dallas.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study investigates whether the way in which individuals process social stimuli can be altered, and specifically, whether feelings of paranoia and suspiciousness can be reduced by stimulating the brain's regulatory regions via transcranial Direct Current Stimulation (tDCS).

Conditions Studied

Interventions

  • DEVICE sham tDCS
  • DEVICE active anodal tDCS

Study Locations (1)

Texas

  • The Unversity of Texas at Dallas - Richardson

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-12-01
Est. Completion 2020-10-01
Phase NA

Sponsor

The University of Texas at Dallas

50 total trials

What the Registry Record Tells You About NCT03374631

The ClinicalTrials.gov registry entry for NCT03374631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 85-participant average among 33 other Healthy Adults trials with a reported enrollment target (53% lower). The listed sponsor is The University of Texas at Dallas, which has 50 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Adults appearing as the primary indexed condition, and to 2 interventions - of which sham tDCS is the first listed.

NCT03374631 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03374631 about?

NCT03374631 is a clinical study titled "Stimulating the Social Brain". This study investigates whether the way in which individuals process social stimuli can be altered, and specifically, whether feelings of paranoia and suspiciousness can be reduced by stimulating the brain's regulatory regions via transcranial Direct Current Stimulation (tDCS).

What is the current status of trial NCT03374631?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-12-01. Estimated completion is 2020-10-01.

What conditions does trial NCT03374631 study?

This clinical trial studies the following conditions: Healthy Adults.

What interventions are being tested in trial NCT03374631?

The interventions under investigation include: sham tDCS (DEVICE), active anodal tDCS (DEVICE).

Who is sponsoring clinical trial NCT03374631?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03374631 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Adults

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.